[Diagnostic problems in congenital thrombocytopathies (author's transl)]

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

Oncology reports·2011

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Oncology reports·2011

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

International journal of oncology·2011

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

International journal of oncology·2011

A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite.

Journal of the European Academy of Dermatology and Venereology : JEADV·2010

Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

Journal of neural transmission (Vienna, Austria : 1996)·2008

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Haematologica·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Haematologica·2026

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

Haematologica·2026

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

Effectiveness and safety of reperfusion strategies within 4.5 hours for large-vessel occlusion stroke: a network meta-analysis.

Stroke and vascular neurology·2026

Predictors for Blood Transfusion Risk in Patients Undergoing Total Hip Arthroplasty for Femoral Neck Fracture: A Two-Center Retrospective Cohort Study.

The Journal of arthroplasty·2026

Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.

Transplantation and cellular therapy·2026

Cumulative Low-Level Viraemia Is Not Associated with Endothelial Function in Black African Adults With HIV.

Journal of acquired immune deficiency syndromes (1999)·2026

Whole Blood Flow Cytometric Quantification of Tissue Factor-Positive Platelets: A Harmonized Multicenter Workflow.

Journal of visualized experiments : JoVE·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Related Experiment Videos

[Diagnostic problems in congenital thrombocytopathies (author's transl)]

Related Concept Videos

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite.

Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Effectiveness and safety of reperfusion strategies within 4.5 hours for large-vessel occlusion stroke: a network meta-analysis.

Predictors for Blood Transfusion Risk in Patients Undergoing Total Hip Arthroplasty for Femoral Neck Fracture: A Two-Center Retrospective Cohort Study.

Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.

Cumulative Low-Level Viraemia Is Not Associated with Endothelial Function in Black African Adults With HIV.

Whole Blood Flow Cytometric Quantification of Tissue Factor-Positive Platelets: A Harmonized Multicenter Workflow.

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Related Experiment Videos

[Diagnostic problems in congenital thrombocytopathies (author's transl)]

Related Concept Videos

Related Articles